Palvella Therapeutics, Inc. (PVLA) Exchange Rate Effect (2016 - 2022)
Palvella Therapeutics (PVLA) has disclosed Exchange Rate Effect for 11 consecutive years, with $3000.0 as the latest value for Q4 2024.
- On a quarterly basis, Exchange Rate Effect rose 104.0% to $3000.0 in Q4 2024 year-over-year; TTM through Dec 2024 was $3000.0, a N/A change, with the full-year FY2024 number at $3000.0, changed N/A from a year prior.
- Exchange Rate Effect was $3000.0 for Q4 2024 at Palvella Therapeutics, up from -$75000.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $2.2 million in Q3 2020 to a low of -$3.3 million in Q2 2022.
- A 5-year average of -$212764.7 and a median of -$75000.0 in 2023 define the central range for Exchange Rate Effect.
- Peak YoY movement for Exchange Rate Effect: soared 515.81% in 2020, then plummeted 10268.75% in 2022.
- Palvella Therapeutics' Exchange Rate Effect stood at $2.0 million in 2020, then tumbled by 144.33% to -$903000.0 in 2021, then soared by 315.39% to $1.9 million in 2022, then plummeted by 103.86% to -$75000.0 in 2023, then soared by 104.0% to $3000.0 in 2024.
- Per Business Quant, the three most recent readings for PVLA's Exchange Rate Effect are $3000.0 (Q4 2024), -$75000.0 (Q4 2023), and -$337000.0 (Q3 2023).